SHELTON, CT / ACCESSWIRE / November 15, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel ...
Vaccine development is inherently challenging; however, in light of the COVID-19 pandemic, innovations have been prioritized, leading to accelerated development processes. Vaccines are known to be ...
Oral and inhaled biologics are gaining R&D investment due to patient acceptance and potential for home administration, with ...
Hyderabad, India: Asia's leading Discovery Research and Development organization, GVK BIO, announced the extended collaboration with Melbourne, Australia based clinical stage biopharmaceutical company ...
Scientists have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine learning algorithms to accelerate drug ...
During the development of biopharmaceuticals, decision has to be made at the outset whether a biopharmaceutical will be delivered in powder or liquid form. To that end, both powder and liquid ...
Embrace Technology Innovations to Optimise LNP Formulation, Alternative LNP Raw Materials, Process Control to Achieve Seamless Scale-Up, Compliance & Cost Effectiveness The inaugural LNP Formulation & ...
Adjuvants have proven to be key components in vaccines that are today taken for granted. Indeed, many vaccines, comprised of whole or killed bacteria or viruses, have inherent immune-potentiating ...
For decades commercial and academic scientists have sought reliable serum-free media. As far back as the 1960s a number of options were available for the cultivation of some cell lines. Now, after ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback